Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Terbutaline
Eligibility
Inclusion Criteria::
- nonreassuring fetal heart rate tracing Exclusion Criteria:- maternal cardiac disease,
placental abruption, intrauterine growth restriction, prior cesarean section
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Yasser El-Sayed
6507233198
Not Recruiting
Our research team includes physicians, residents, medical students, research assistants, and volunteers. Our research topics include medical imaging, device validation, mobile application development, and pharmaceutical trials.
Some of the Neuro-Opthalmic concerns we investigate include Multiple Sclerosis, Optic Neuritis, IIH, and ICP.